Addressing the Escalating Health Concerns
Pune, 05.08.2023 – The Anti-Obesity Drugs Market is set to exhibit substantial growth, projected to expand at a steady Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period. The market is anticipated to achieve an impressive valuation of nearly US$ 3.78 billion by 2029. The latest report from MMR delves into the market's comprehensive analysis, exploring market values, scope, research methodology, drivers, restraints, and regional insights.
Anti-Obesity Drugs Market Overview:
As global health concerns surge, the Anti-Obesity Drugs Market takes center stage in addressing the mounting issue of obesity. Past studies indicate a significant increase in obesity cases, with data revealing that the number of obese individuals has tripled from 1965 to 2021, reaching a staggering 1.6 billion individuals. Obesity's far-reaching impact encompasses heightened risks of chronic diseases, including endometrial cancer, breast cancer, colon cancer, type 2 diabetes, cardiovascular diseases, and musculoskeletal disorders.
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/request-sample/36441
What are Anti-Obesity Drugs Market Dynamics:
The report delves into the drivers and restraints shaping the Anti-Obesity Drugs Market. With a comprehensive analysis of revenue impact in the wake of the COVID-19 pandemic, the report highlights the escalating obesity rates, particularly in the United States, where over 68.8% of the population is classified as obese. The growing awareness of obesity-related health risks is propelling individuals towards anti-obesity drugs as a viable solution. Obesity's status as a chronic disease, coupled with its associated health risks, is motivating patients to explore prescription weight loss drugs as a potential intervention.
Advancements in drug delivery methods, including skin patch delivery and Nano Soy-Phytosome based thermo gels, are revolutionizing the anti-obesity prescription drugs market, offering improved effectiveness and reduced side effects. Herbal supplements are a noteworthy trend, fostering opportunities for market growth. Notably, top FDA-approved drugs such as Contrave, Belviq, Xenical, Saxenda, and Qsymia are shaping the landscape, with Saxenda by Novo Nordisk Pharma gaining remarkable traction.
Anti-Obesity Drugs Market Regional Insights:
North America takes the lead in the global anti-obesity prescription drugs market, owing to heightened awareness and risks associated with obesity. The Asia Pacific region is poised for significant growth, driven by rising obesity rates. The European Medicines Agency's regulatory stance and the withdrawal of certain anti-obesity drugs underscore the market's evolution.
Request For Customization Report:
What is Anti-Obesity Drugs Market Segmentation:
The Anti-Obesity Prescription Drugs Market is segmented based on type, drug class, sales channel, application, and region. The market embraces both prescription drugs and over-the-counter (OTC) drugs, catering to diverse pharmacological needs. The distribution channels span Hospital Pharmacies, E-Commerce, and Retail Pharmacies, while drug classes include peripherally acting and centrally acting anti-obesity drugs.
by Drug Type
• Contrave
• Belviq
• Xenical
• Saxenda
• Qsymia
by Type
• Prescription Drugs
• OTC Drugs
by Drug class
• Peripherally Acting Anti-obesity Drugs
• Centrally Acting Anti-obesity Drugs
by Sales channel
• Direct Channel
• Distribution Channel
by Application
• Hospitals Pharmacies
• Retail Pharmacies
• E-commerce
Who are Anti-Obesity Drugs Market Key Players:
• F Hoffmann La Roche
• Arena Pharmaceuticals
• Orexigen Therapeutics
• Phentermine and Topiramate
• VIVUS, Inc
• Liraglutide
• Bupropion and Naltrexone
• Orlistat
• Novo Nordisk
• Lorcaserin
• GlaxoSmith Kline
• Eisai Co, Ltd
• Boehringer Ingelheim
• Merck & Co
• Pfizer
• Rhythm Pharmaceuticals
• Zafgan
• Takeda Pharmaceuticals
• Novo Nordisk
• Bristol-Myers Squibb Co.
• Shionogi USA Inc
To know about the Research Methodology :- https://www.maximizemarketresearch.com/request-sample/36441
Table of content for the Anti-Obesity Drugs Market includes:
- Global Anti-Obesity Drugs Market : Research Methodology
- Global Anti-Obesity Drugs Market : Executive Summary
- Market Overview and Definitions
- Introduction to the Global Market
- Summary
- Key Findings
- Recommendations for Investors
- Recommendations for Market Leaders
- Recommendations for New Market Entry
3.Global Anti-Obesity Drugs Market : Competitive Analysis
- MMR Competition Matrix
- Market Structure by region
- Competitive Benchmarking of Key Players
- Consolidation in the Market
- MA by region
- Key Developments by Companies
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Challenges
- Market Dynamics
- PORTERS Five Forces Analysis
- PESTLE
- Regulatory Landscape by region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America
- COVID-19 Impact
- Global Anti-Obesity Drugs Market Segmentation
- Global Market, by Drug Type(2022-2029)
- Global Market, by Type (2022-2029)
- Global Market, by Drug class (2022-2029)
- Global Market, by Sales channel (2022-2029)
- Global Market, by Application (2022-2029)
- Regional Anti-Obesity Drugs Market (2022-2029)
- Regional Market, by Drug Type (2022-2029)
- Regional Market, by Type (2022-2029)
- Regional Market, by Drug class(2022-2029)
- Regional Market, by Sales channel (2022-2029)
- Regional Market, by Application(2022-2029)
- Regional Market, by Country (2022-2029)
- Company Profile: Key players
- Company Overview
- Financial Overview
- Global Presence
- Capacity Portfolio
- Business Strategy
- Recent Developments
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2021)
- Past Pricing and price curve by region (2018 to 2021)
- Market Size, Share, Size Forecast by different segment | 2022−2029
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
- Market Segmentation – A detailed analysis by Type , Technology and End-User
- Competitive Landscape – Profiles of selected key players by region from a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of business by region
- Lucrative business opportunities with SWOT analysis
- Recommendations
More Related Reports:
Global Automotive Software Market https://www.maximizemarketresearch.com/market-report/global-automotive-software-market/22003/
Global Tea Market https://www.maximizemarketresearch.com/market-report/global-tea-market/19202/
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of the majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT telecom, chemical, food beverage, aerospace defense, healthcare and others.
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
✆ +1 800 507 4489
✆ +91 9607365656
